Fresh analysis reveals that people who come off new slimming jabs like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who halt traditional diet and exercise regimens.
Published data in a leading health publication demonstrates that while obese individuals often shed a large proportion of their total mass while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"People purchasing these treatments need to be aware of the risk of quick weight regain when the medication is stopped," warns researcher Dr. Susan Jebb.
Such speed of regain implies a reversion to original mass within about a year and a half.
Comparing Therapies
The research, which looked at 37 of studies involving over 9,000 of participants, compared the effects of these new drugs with conventional dieting.
Researchers emphasize that individuals who shed pounds through dieting typically see a slower creep back—perhaps 100 grams monthly—once they finish.
The Reason for the Quick Rebound
Doctors propose the way of the drugs explains the heightened regain.
The injections copy a body's own chemical called GLP-1, which moderates feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its endogenous hormone, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' leads to hunger is uncontrolled, making excessive eating much more probable."
A Chronic Condition?
Health authorities suggest the jabs for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
Many experts argue that, considering the significant potential of weight regain, the treatment should be considered life-long.
This view is supported by pharmaceutical companies, who note that the results "emphasize the long-term nature of excess weight," akin to managing diseases like high blood pressure.
User Accounts
Individuals who have stopped the medication explain a sudden resurgence of cravings.
"I experienced a trigger that goes on and you become starving," described an individual.
This difficulty is worsened if patients have not developed sustainable dietary or behavioural modifications during treatment.
Widespread Interest
Figures indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.
- Use is greater among women than males.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than public health services.
In conclusion, researchers caution that while GLP-1 drugs are effective tools for shedding pounds, they are not a permanent fix and lasting health benefits hinges on ongoing behavioural changes.
